ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Records Clear Flood Of Intervention For Man Accused Of Illegal Payoffs

February 3, 1978

Patient Advocacy: Committee To Advise NCI On Formation Of Liaison Group

February 28, 1997

Three Studies Demonstrate Oncotype DX Test Effectiveness

March 30, 2012

In Brief: Cancer Panel To Meet In Seattle, Houston, Chicago; Wisconsin’s Robert Johnson Dies; Goldin Retires

August 27, 1982

Ad Hoc Internet Group Send Rebuttal To Scher’s Letter.

April 27, 2007

Bush Proposes 16 Percent Increase For NIH, To Complete Budget Doubling.

February 1, 2002